A different scoring method developed to quantify estrogen and progesterone receptors in breast cancers, the Allred score [2, 12], assigns separate categorical scores for the intensity (0–3) and the proportion (0–5) of the biomarkers in immunolabeled specimens, and the final score is the sum of these two scores. This evidence concerns the gene PGR and breast cancer.